BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32669499)

  • 1. Impact of Metabolic Syndrome on the Mortality Rate among Participants in a Specific Health Check and Guidance Program in Japan.
    Iseki K; Konta T; Asahi K; Yamagata K; Fujimoto S; Tsuruya K; Narita I; Kasahara M; Shibagaki Y; Moriyama T; Kondo M; Iseki C; Watanabe T
    Intern Med; 2020 Nov; 59(21):2671-2678. PubMed ID: 32669499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality risk among screened subjects of the specific health check and guidance program in Japan 2008-2012.
    Iseki K; Asahi K; Yamagata K; Fujimoto S; Tsuruya K; Narita I; Konta T; Kasahara M; Shibagaki Y; Yoshida H; Moriyama T; Kondo M; Iseki C; Watanabe T;
    Clin Exp Nephrol; 2017 Dec; 21(6):978-985. PubMed ID: 28258498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome and all-cause and cardiovascular disease mortality: Japan Public Health Center-based Prospective (JPHC) Study.
    Saito I; Iso H; Kokubo Y; Inoue M; Tsugane S
    Circ J; 2009 May; 73(5):878-84. PubMed ID: 19282609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of dipstick hematuria with all-cause mortality in the general population: results from the specific health check and guidance program in Japan.
    Iseki K; Konta T; Asahi K; Yamagata K; Fujimoto S; Tsuruya K; Narita I; Kasahara M; Shibagaki Y; Moriyama T; Kondo M; Iseki C; Watanabe T;
    Nephrol Dial Transplant; 2018 May; 33(5):825-832. PubMed ID: 28992249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort.
    Guembe MJ; Fernandez-Lazaro CI; Sayon-Orea C; Toledo E; Moreno-Iribas C;
    Cardiovasc Diabetol; 2020 Nov; 19(1):195. PubMed ID: 33222691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dipstick proteinuria and all-cause mortality among the general population.
    Iseki K; Konta T; Asahi K; Yamagata K; Fujimoto S; Tsuruya K; Narita I; Kasahara M; Shibagaki Y; Moriyama T; Kondo M; Iseki C; Watanabe T
    Clin Exp Nephrol; 2018 Dec; 22(6):1331-1340. PubMed ID: 29869754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of the all-cause and cardiovascular disease related mortality risk with changes in the metabolic syndrome status: a population-based prospective cohort study in Taiwan.
    Lai YJ; Yen YF; Chen LJ; Hsu LF; Ahmadi MN; Inan-Eroglu E; Ku PW; Stamatakis E
    Diabetes Metab; 2023 May; 49(3):101415. PubMed ID: 36563960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between metabolic syndrome and mortality from cardiovascular disease in Japanese general population, findings on overweight and non-overweight individuals. Ibaraki Prefectural Health Study.
    Irie F; Iso H; Noda H; Sairenchi T; Otaka E; Yamagishi K; Doi M; Izumi Y; Ota H
    Circ J; 2009 Sep; 73(9):1635-42. PubMed ID: 19590142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolic syndrome increases cardiovascular mortality in Taiwanese elderly.
    Wen CJ; Lee YS; Lin WY; Huang HL; Yao CA; Sung PK; Huang KC
    Eur J Clin Invest; 2008 Jul; 38(7):469-75. PubMed ID: 18505405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of metabolic syndrome with risk of cardiovascular disease mortality and all-cause mortality among Malaysian adults: a retrospective cohort study.
    Chee Cheong K; Lim KH; Ghazali SM; Teh CH; Cheah YK; Baharudin A; Lim HL; Abdul Hamid AM; Mustapha FI; Omar MA
    BMJ Open; 2021 Aug; 11(8):e047849. PubMed ID: 34408040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between renal function and cardiovascular and all-cause mortality in the community-based elderly population: results from the Specific Health Check and Guidance Program in Japan.
    Kon S; Konta T; Ichikawa K; Asahi K; Yamagata K; Fujimoto S; Tsuruya K; Narita I; Kasahara M; Shibagaki Y; Iseki K; Moriyama T; Kondo M; Watanabe T
    Clin Exp Nephrol; 2018 Apr; 22(2):346-352. PubMed ID: 28744566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association between lifestyle factors assessed by standard question items of specific health checkup and the incidence of metabolic syndrome and hypertension in community dwellers: A five-year cohort study of National Health Insurance beneficiaries in Habikino City].
    Tsutatani H; Funamoto M; Sugiyama D; Kuwabara K; Miyamatsu N; Watanabe K; Okamura T
    Nihon Koshu Eisei Zasshi; 2017; 64(5):258-269. PubMed ID: 28626153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of Metabolic Syndrome and its Components With Mortality in the Elderly: A Cohort Study of 73,547 Taiwanese Adults.
    Yen YF; Hu HY; Lin IF; Lai YJ; Su VY; Pan SW; Ting WY; Su WJ
    Medicine (Baltimore); 2015 Jun; 94(23):e956. PubMed ID: 26061328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased medical costs in elders with the metabolic syndrome are most evident with hospitalization of men.
    Chang YH; Chen RC; Lee MS; Wahlqvist ML
    Gend Med; 2012 Oct; 9(5):348-60. PubMed ID: 23000153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of metabolic syndrome on 10-year clinical outcomes among patients with acute coronary syndrome.
    Dohi T; Miyauchi K; Kasai T; Kajimoto K; Kubota N; Tamura H; Yokoyama T; Kojima T; Yokoyama K; Kurata T; Daida H
    Circ J; 2009 Aug; 73(8):1454-8. PubMed ID: 19531901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Cohort Study on Prediction of Incidence of All-Cause Mortality by Metabolic Syndrome.
    Li Z; Yang X; Yang J; Yang Z; Wang S; Sun F; Zhan S
    PLoS One; 2016; 11(5):e0154990. PubMed ID: 27195697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of preexisting metabolic syndrome as defined by Japanese original criteria among patients with non-fatal myocardial infarction.
    Hamada R; Muto S; Otsuka N; Sato E; Zhang Y
    Intern Med; 2011; 50(22):2749-57. PubMed ID: 22082886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.
    Lakka HM; Laaksonen DE; Lakka TA; Niskanen LK; Kumpusalo E; Tuomilehto J; Salonen JT
    JAMA; 2002 Dec; 288(21):2709-16. PubMed ID: 12460094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome, its components, and mortality in the elderly.
    Akbaraly TN; Kivimaki M; Ancelin ML; Barberger-Gateau P; Mura T; Tzourio C; Touchon J; Ritchie K; Berr C
    J Clin Endocrinol Metab; 2010 Nov; 95(11):E327-32. PubMed ID: 20810578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.
    Malik S; Wong ND; Franklin SS; Kamath TV; L'Italien GJ; Pio JR; Williams GR
    Circulation; 2004 Sep; 110(10):1245-50. PubMed ID: 15326067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.